1.Provide new insights into drug discovery for schizophrenia
2.There has been little progress in this field since the 1950s
3.MedChemComm, Toxicology Research, Issues in Toxicology Series
4.Geneticists, pharmacologists, molecular biologists and medicinal chemists in academia and industry.
5.Will fill the gaps in knowledge of neurobiology of schizophrenia and providing novel perspectives in drug development.
Additional information
Weight
0.596 kg
Product Properties
Year of Publication
2015
Table of Contents
Genetics of schizophrenia: Genome-Wide Association Study; Epigenetics of schizophrenia; Cognitive dysfunction in schizophrenia; Modelling schizophrenia; Glutamate hypothesis of schizophrenia; Dopamine hypothesis of schizophrenia; Neurodevelopmental hypothesis of schizophrenia; Genetic factors and hippocampal dysfunction in schizophrenia; Exome study of schizophrenia; Protein-protein interactions as a potentially new drug target in schizophrenia; Optogenetic approach to dissect neurobiology of schizophrenia; MicroRNAs in neuronal function and dysfunction; Application of pluripotent stem cells in schizophrenia; Deep brain stimulation of the hippocampus and prefrontal cortex as alternative approach in treatment of schizophrenia; Neuroimmunology of brain development in schizophrenia and immunotherapy
Author
Tatiana Lipina,
ISBN/ISSN
9781782620266
Binding
Hardback
Edition
1
Publisher
Royal Society of Chemistry
Reviews
There are no reviews yet.
Be the first to review “Drug Discovery for Schizophrenia” Cancel reply
Reviews
There are no reviews yet.